NCT05538572 2024-07-01A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid TumorsPrelude TherapeuticsPhase 1 Completed22 enrolled
NCT04430842 2023-01-18Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072SQuadriga Biosciences, Inc.Phase 1 Completed15 enrolled
NCT00030498 2013-01-16Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionNational Cancer Institute (NCI)Phase 1 Completed75 enrolled
NCT00020579 2012-03-15MS-275 in Treating Patients With Advanced Solid Tumors or LymphomaNational Institutes of Health Clinical Center (CC)Phase 1 Completed75 enrolled